Assessing Artificial Pancreas Performance in T2DM

in American Diabetes Association: 77th Scientific Sessions / ADA 2017, in Diabetes, vol. 66, no. Supplement 1, pp. A274 (1039-P), 2017
Author(s):Reiter M., Reiterer F., Bechmann Christensen M., Norgaard K., Del Re L.
Advanced insulin dosing options have been extensively studied for T1D, but little effort has been made for T2D, although closed loop insulin delivery has been shown to be feasible also for this group of patients.
Sign in
Aucun animal n'a été blessé lors la conception de ce site web